Lee Yun-Hee, Kim Sang-Nam, Kwon Hyun-Jung, Maddipati Krishna Rao, Granneman James G
College of Pharmacy, Yonsei University, Incheon, South Korea;
Lipidomics Core Facility and Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan; and.
Am J Physiol Regul Integr Comp Physiol. 2016 Jan 1;310(1):R55-65. doi: 10.1152/ajpregu.00355.2015. Epub 2015 Nov 4.
De novo brown adipogenesis involves the proliferation and differentiation of progenitors, yet the mechanisms that guide these events in vivo are poorly understood. We previously demonstrated that treatment with a β3-adrenergic receptor (ADRB3) agonist triggers brown/beige adipogenesis in gonadal white adipose tissue following adipocyte death and clearance by tissue macrophages. The close physical relationship between adipocyte progenitors and tissue macrophages suggested that the macrophages that clear dying adipocytes might generate proadipogenic factors. Flow cytometric analysis of macrophages from mice treated with CL 316,243 identified a subpopulation that contained elevated lipid and expressed CD44. Lipidomic analysis of fluorescence-activated cell sorting-isolated macrophages demonstrated that CD44+ macrophages contained four- to five-fold higher levels of the endogenous peroxisome-proliferator activated receptor gamma (PPARγ) ligands 9-hydroxyoctadecadienoic acid (HODE), and 13-HODE compared with CD44- macrophages. Gene expression profiling and immunohistochemistry demonstrated that ADRB3 agonist treatment upregulated expression of ALOX15, the lipoxygenase responsible for generating 9-HODE and 13-HODE. Using an in vitro model of adipocyte efferocytosis, we found that IL-4-primed tissue macrophages accumulated lipid from dying fat cells and upregulated expression of Alox15. Furthermore, treatment of differentiating adipocytes with 9-HODE and 13-HODE potentiated brown/beige adipogenesis. Collectively, these data indicate that noninflammatory removal of adipocyte remnants and coordinated generation of PPARγ ligands by M2 macrophages provides localized adipogenic signals to support de novo brown/beige adipogenesis.
从头开始的棕色脂肪生成涉及祖细胞的增殖和分化,然而,在体内指导这些过程的机制仍知之甚少。我们之前证明,用β3-肾上腺素能受体(ADRB3)激动剂处理后,性腺白色脂肪组织中的脂肪细胞死亡并被组织巨噬细胞清除,随后会引发棕色/米色脂肪生成。脂肪细胞祖细胞与组织巨噬细胞之间紧密的物理关系表明,清除濒死脂肪细胞的巨噬细胞可能会产生促脂肪生成因子。对用CL 316,243处理的小鼠的巨噬细胞进行流式细胞术分析,确定了一个脂质含量升高且表达CD44的亚群。对荧光激活细胞分选分离的巨噬细胞进行脂质组学分析表明,与CD44-巨噬细胞相比,CD44+巨噬细胞中内源性过氧化物酶体增殖物激活受体γ(PPARγ)配体9-羟基十八碳二烯酸(HODE)和13-HODE的水平高四至五倍。基因表达谱分析和免疫组织化学表明,ADRB3激动剂处理上调了负责生成9-HODE和13-HODE的脂氧合酶ALOX15的表达。使用脂肪细胞胞葬作用的体外模型,我们发现IL-4预处理的组织巨噬细胞从濒死脂肪细胞中积累脂质并上调Alox15的表达。此外,用9-HODE和13-HODE处理分化中的脂肪细胞可增强棕色/米色脂肪生成。总体而言,这些数据表明,M2巨噬细胞对脂肪细胞残余物的非炎性清除以及PPARγ配体的协同生成提供了局部脂肪生成信号,以支持从头开始的棕色/米色脂肪生成。